ISSN: 2689-8993
Associate Professor
Deptartment of Neurosciences
School of Medicine
University of California
San Diego, United States of America
Dr. Steven L Wagner is an Associate Professor in Department of Neurosciences at University of California. Dr. Wagner joined the School of Medicine at the University of California from 2009-2013. Prior to that He co-founded TorreyPines Therapeutics, then named Neurogenetics, in 2000 serving as its Chief Scientific Officer for nine years. Previously, He was the Director of Protein Biochemistry at SIBIA Neurosciences from 1991-1999. He served as the program head of SIBIA's Alzheimer's disease drug discovery collaboration with Bristol-Myers Squibb (BMS). This collaboration resulted in the first gamma-secretase inhibitor for Alzheimer's disease to reach the clinic. Dr. Wagner was a member of SIBIA's Strategic Planning and Drug Discovery Steering Committees and a member of the Joint Steering Committee between SIBIA and BMS. He is an inventor on numerous patents and patent applications and has published over 50 chapters and research papers in the top scientific journals. Prior to leading SIBIA's Alzheimer's disease drug discovery efforts, He was a Research Associate Professor in the Department of Microbiology and Molecular Genetics at the University of California at Irvine where he co-authored the initial purification and identification of the human amyloid precursor protein (APP). He received his B.S. in chemistry from Bellarmine College and received his M.S. and Ph.D. in biochemistry from the Health Sciences Center at the University of Louisville School of Medicine.
